Catheter Precision Inc. has entered into a Securities Purchase Agreement with three investors on May 12, 2025. The company sold a total of 1.5 million shares of its newly designated Series B Convertible Preferred Stock for a stated value of $1.5 million. Additionally, Catheter Precision issued another 1.5 million shares of the same stock as consideration to one investor in exchange for existing senior secured Convertible Promissory Notes of QHSLab, Inc. A total of 8,574,000 shares of common stock have been reserved for issuance upon conversion of the Series B Convertible Preferred Stock.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.